down arrow

Samrat Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE103E01016
  • NSEID:
  • BSEID: 530125
  • View on BSE
INR
232.00
8.95 (4.01%)
BSENSE

Sep 25, 03:30 PM

BSE+NSE Vol: 2.26 k

Access older stock analysis version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Samrat Pharmachem Ltd stock-summary
stock-summary
Samrat Pharmachem Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Samrat Pharmachem Limited (SPL) was incorporated on June 16, 1992 at Ankleshwar in Gujarat led by the Promoters, Mr. Lalit Mehta & Mr. Rajesh Mehta. Since then, it focused on lodine Derivatives as their core products. Company is a producer of pharmaceutical chemicals. The intermediates produced are used in pharmaceutical and chemical industries. The Company is amongst the manufacturers who produce for local and international needs of the pharmaceuticals and chemicals industry.
Company Coordinates stock-summary
Company Details
Plot No A2/3445, GIDC Phase IV Ankleshwar Gujarat : 393002
stock-summary
Tel: 91-2646-220774
stock-summary
http://www.samratpharmachem.com
stock-summary
samrat@bom4.vsnl.net.in
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Lalit Damodar Mehta (13.97%)

Highest Public shareholder

Sangeetha S (3.27%)

Individual Investors Holdings

41.51%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Lalit Mehta
Chairman & Managing Director
36.0 lacs
Rajesh Mehta
Director & CFO
30.0 lacs
Mahendra Pipalia
Independent Director
2.0 lacs
Samir Kothary
Independent Director
2.0 lacs
Renu P Dharod
Independent Director
2.0 lacs
Megh Mehta
Executive Director
15.0 lacs
Nishant Kankaria
Company Sec. & Compli. Officer
2.43 lacs
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
80 Cr
(Quarterly Results - Jun 2026)
Net Profit:
1 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 69 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

38

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.06

stock-summary
Return on Equity

-3.24%

stock-summary
Price to Book

1.01

Footer loading